Stat3 as a potential therapeutic target for rheumatoid arthritis

Takatsugu Oike, Yuiko Sato, Tami Kobayashi, Kana Miyamoto, Satoshi Nakamura, Yosuke Kaneko, Shu Kobayashi, Kengo Harato, Hideyuki Saya, Morio Matsumoto, Masaya Nakamura, Yasuo Niki, Takeshi Miyamoto

研究成果: Article査読

48 被引用数 (Scopus)


Rheumatoid arthritis (RA) is a multi-factorial disease characterized by chronic inflammation and destruction of multiple joints. To date, various biologic treatments for RA such as anti-Tumor necrosis factor alpha antibodies have been developed; however, mechanisms underlying RA development remain unclear and targeted therapy for this condition has not been established. Here, we provide evidence that signal transducer and activator of transcription 3 (Stat3) promotes inflammation and joint erosion in a mouse model of arthritis. Stat3 global KO mice show early embryonic lethality; thus, we generated viable Stat3 conditional knockout adult mice and found that they were significantly resistant to collagen-induced arthritis (CIA), the most common RA model, compared with controls. We then used an in vitro culture system to screen ninety-six existing drugs to select Stat3 inhibitors and selected five candidate inhibitors. Among them, three significantly inhibited development of arthritis and joint erosion in CIA wild-Type mice. These findings suggest that Stat3 inhibitors may serve as promising drugs for RA therapy.

ジャーナルScientific reports
出版ステータスPublished - 2017 12月 1

ASJC Scopus subject areas

  • 一般


「Stat3 as a potential therapeutic target for rheumatoid arthritis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。